
World Rank (Jan-07-2022)
27
Market Cap (Jan-07-2022)
312.750 Billion USD
World Rank (Sep-01-2021)
36
Market Cap (Sep-01-2021)
258.300 Billion USD
World Rank (Jan-01-2021)
46
Market Cap (Jan-01-2021)
204.600 Billion USD
World Rank (Jan-2020)
37
Market Cap (Jan 1st 2020)
215.483 Billion USD
Annual Revenue in USD
81,288 Million USD
Annual Net Income in USD
21,980 Million USD
Annual Results for Year Ending
Dec-2021
Total Assets in USD
154,230 Million USD
Total Liabilities in USD
90,991 Million USD
Total Equity in USD
63,238 Million USD
Balance Sheet Summary for Period ending
Dec-2020
Headquarters Region / City
Headquarters Country
Headquarters Sub Region
Headquarters Continent
Company Business
Stock Category
Stock Exchange
Company Rank in Country in 2022
Company Rank in USA in 2022 is 18
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 29
Rank in Country (Jan-2020)
Rank in USA in 2020 is 25
Number of Employees
78,500
Employee Count as on Date
As on May 2021
Chairman
CEO:
Founders
Company Website:
Pfizer is expanding Phase 3 Trials to test Covid-19 Vaccine
Pfizer and BioNTech planning to expand phase 3 trials to test Covid-19 vaccine. From initial plan of 30,000 people, now they are planning to conduct trials of Covid-19 vaccine on 44,000 people. They are expecting results by Oct-2020 ending.